Veerhealth Care Ltd vs Sun Pharmaceutical Industries Ltd

A side-by-side comparison of Veerhealth Care Ltd (511523) and Sun Pharmaceutical Industries Ltd (MIL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Sun Pharmaceutical Industries Ltd leads 511523 vs MIL on 7 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability31
  • Growth10
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

MIL takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

153.60
P/E ratio
36.90
3.62
P/B ratio
5.35
0.00%
Dividend yield
0.86%
₹0.20
EPS
₹0.68

Profitability

511523 takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

2.97%
Return on equity
-6.70%
3.14%
Return on capital
-1.00%
2.76%
EBITDA margin
3.50%
2.34%
Net margin
-13.10%

Growth

511523 takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

34.73%
Revenue CAGR (3Y)
-87.58%
-13.01%
Profit CAGR (3Y) even

Size & financial health

MIL takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹83 Cr
Market cap
₹4.42L Cr
₹17 Cr
Revenue
₹84 Cr
₹0 Cr
Net profit
₹-11 Cr
0.20
Debt / equity
0.06
Veerhealth Care Ltd
  • + ["Company is expected to give good quarter", "Company's working capital requirements have reduced from 158 days to 51.4 days"]
  • ["Stock is trading at 3.62 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend", "Promoter holding is low: 31.9%", "Company has a low return on equity of 2.22% over last 3 years."]
Sun Pharmaceutical Industries Ltd
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Veerhealth Care Ltd full analysis Sun Pharmaceutical Industries Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.